GSK PLC (GSK) — Hedge Fund Ownership Q1 2026
GSK
- GSK PLC (GSK) is held by 6 of 82 tracked hedge funds, with Hillman Capital Management (4%) and Dodge & Cox (2%) holding the largest stakes, indicating limited hedge fund interest relative to peers.
- The biggest increases in GSK holdings came from Pzena Investment Management (+40%), highlighting conviction.
- The biggest decreases in GSK holdings came from Dodge & Cox (-14%) and Causeway Capital Management (-67%), suggesting profit-taking or de-risking.
- 1 hedge fund exited GSK.
- Overall, hedge funds decreased exposure to GSK PLC (GSK) by -14% vs the prior quarter and -27% vs prior year.
| # | Fund | % of Portfolio † | Shares † | Shares vs Prior Quarter † | Shares vs Prior Year † | Aggregate Value † | Reported Price * | Option |
|---|---|---|---|---|---|---|---|---|
| 1 |
Hillman Capital Management Mark Hillman
|
3.73% | 97K | -14.78% | -41.00% | $5.4M | $55.19 | — |
| 2 |
Dodge & Cox
|
1.78% | 58.7M | -14.38% | -25.41% | $3.24B | $55.19 | — |
| 3 |
Kahn Brothers Group Irving Kahn
|
1.58% | 161K | -9.91% | -80.42% | $8.9M | $55.19 | — |
| 4 |
Tweedy, Browne Tweedy, Browne Co LLC
|
0.36% | 82K | -0.56% | -9.67% | $4.5M | $55.19 | — |
| 5 |
Causeway Capital Management
|
0.01% | 11K | -67.22% | -99.00% | $613,177 | $55.19 | — |
| 6 |
Pzena Investment Management Richard Pzena
|
0.00% | 19K | +40.01% | — | $1.0M | $55.19 | — |
| — |
Third Avenue Management
|
— | — | EXITED | — | — | — | — |
| 6 | Total | — | 59.0M | -14.47% | -27.08% | $3.26B | — | — |
* Reported price is not an actual purchase or sale price. It is the price as of the last portfolio date.
† Portfolio value, share counts, and period-over-period changes exclude options positions (PUT/CALL), which are shown in the Option column for reference only.
† Portfolio value, share counts, and period-over-period changes exclude options positions (PUT/CALL), which are shown in the Option column for reference only.